18.02.2021 | Magenkarzinom | Journal Club
Avelumab beim Magenkarzinom: JAVELIN Gastric 100
- Zeitschrift:
- Der Onkologe
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Anzeige
1.
Zurück zum Zitat Chung HC, Arkenau HT, Lee J, Rha SY, Oh DY, Wyrwicz L, Kang YK, Lee KW, Infante JR, Lee SS, Kemeny M, Keilholz U, Melichar B, Mita A, Plummer R, Smith D, Gelb AB, Xiong H, Hong J, Chand V, Safran H (2019) Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial. J Immunother Cancer 7(1):30. https://doi.org/10.1186/s40425-019-0508-1 CrossRefPubMedPubMedCentral Chung HC, Arkenau HT, Lee J, Rha SY, Oh DY, Wyrwicz L, Kang YK, Lee KW, Infante JR, Lee SS, Kemeny M, Keilholz U, Melichar B, Mita A, Plummer R, Smith D, Gelb AB, Xiong H, Hong J, Chand V, Safran H (2019) Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial. J Immunother Cancer 7(1):30.
https://doi.org/10.1186/s40425-019-0508-1
CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Wagner AD, Syn NL, Moehler M, Grothe W, Yong WP, Tai BC, Ho J, Unverzagt S (2017) Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004064.pub4 CrossRefPubMedPubMedCentral Wagner AD, Syn NL, Moehler M, Grothe W, Yong WP, Tai BC, Ho J, Unverzagt S (2017) Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev.
https://doi.org/10.1002/14651858.CD004064.pub4
CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Gulley JL, Rajan A, Spigel DR, Iannotti N, Chandler J, Wong D, Leach J, Edenfield WJ, Wang D, Grote HJ, Heydebreck AV, Chin K, Cuillerot JM, Kelly K (2017) Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial. Lancet Oncol 18(5):599–610. https://doi.org/10.1016/S1470-2045(17)30240-1 CrossRefPubMedPubMedCentral Gulley JL, Rajan A, Spigel DR, Iannotti N, Chandler J, Wong D, Leach J, Edenfield WJ, Wang D, Grote HJ, Heydebreck AV, Chin K, Cuillerot JM, Kelly K (2017) Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial. Lancet Oncol 18(5):599–610.
https://doi.org/10.1016/S1470-2045(17)30240-1
CrossRefPubMedPubMedCentral
- Titel
- Avelumab beim Magenkarzinom: JAVELIN Gastric 100
- Autoren:
-
Milan Hartmann
Fabian Kütting
PD Dr. med. Hakan Alakus
Prof. Dr. Christiane Bruns
- Publikationsdatum
- 18.02.2021
- Schlagwörter
- Magenkarzinom
Magenkarzinom - DOI
- https://doi.org/10.1007/s00761-021-00918-7
- Verlag
- Springer Medizin
- Zeitschrift
-
Der Onkologe
Print ISSN: 0947-8965
Elektronische ISSN: 1433-0415